Global Pharma And Biotech Summit 2024 | FT Live | 4 November 2024 | Hilton London Bankside, 2-8 Great Suffolk St, London SE1 0UG, UK

The world of life sciences is in a period of relentless disruption. Advances in technology are transforming research and development. Innovative treatments such as mRNA vaccines and cell therapies are reshaping healthcare as we know it. Meanwhile, companies face the challenge of bringing products to market in an unsettled regulatory environment.

The Summit is the essential annual event for you to stay on top of the latest trends and innovations in life sciences. Industry leaders and experts will discuss what’s new in areas such as drug discovery, clinical trials, market access and patient engagement.

Why attend?
• Understand
Tthe technology and innovation behind new treatments with the power to transform healthcare.
• Connect
With industry leaders responsible for the big decisions in areas such as investment, innovation and market access.
• Discover
New ideas to support business transformation and maximise return on investment.

2024 Speakers

MODERATORS:

Drew Armstrong
Executive Editor, Endpoints News

Oliver Barnes
US Pharmaceutical and Biotech Correspondent, Financial Times

Andrew Dunn
Senior Biopharma Correspondent, Endpoints News

Laura Hughes
Public Policy Correspondent, Financial Times

Ian Johnston
Global Pharmaceutical Correspondent, Financial Times

Sarah Neville
Global Health Editor, Financial Times

Michael Peel
Science Editor, Financial Times

SPEAKERS:

Robert A. Bradway
Chairman and CEO, Amgen

Emma Walmsley
CEO, GSK

Christophe Weber
President and CEO, Takeda

Demis Hassabis
CEO, Google DeepMind and Isomorphic Labs

Patrick Vallance
Minister of State, Department for Science, Innovation and Technology

Jenny Harries
CEO, UK Health Security Agency

Virginia Acha
Associate Vice President and Global Lead, Global Evidence and Regulatory Policy, MSD

Rohit Alimchandani
Head of Life Sciences, UK and Ireland, Cognizant

Annaliesa Anderson
Senior Vice President, Head of Vaccine Research and Development, Pfizer

Seyda Atadan Memis
General Manager, UK and Ireland, Takeda

Rifat Atun
Professor of Global Health Systems, Harvard University

Barry Balfe
President, ICON Pharma Development Solutions

Fiona Bride
Director of Medicines Value and Access, NHS England

Kylie Bromley
Vice President and Managing Director, United Kingdom and Ireland, Biogen

Francesca Ceddia
Chief Medical Affairs Officer, Moderna

Tony Clarke
Senior Vice President, IT Digital Operations, ICON

Michael Ehlers
General Partner and Chief Scientific Officer, Apple Tree Partners

Michael Elliott
Vice President, Medical Affairs, Europe, Canada and Australasia, Gilead Sciences

Seth Ettenberg
President and CEO, BlueRock Therapeutics

Lauren Fedor
US Political Correspondent and Washington Deputy Bureau Chief, Financial Times

Alexandria Forbes
President and CEO, MeiraGTx

Saira Ghafur
Digital Health Lead, Institute of Global Health Innovation, Imperial College London

Sebastian Guth
President, Bayer US, Chief Operating Officer, Bayer Pharmaceuticals

Doina Ionescu
Managing Director, UK and Ireland, Merck Healthcare

Mads Jessen
Managing Director, Moelis & Company

Jayasree K. Iyer
CEO, Access to Medicine Foundation

Waheed Jamal
Corporate Vice President, Head of Medicine, Cardiovascular, Renal and Metabolism, Boehringer Ingelheim

Panos Kanavos
Associate Professor of International Health Policy, London School of Economics and Political Science

Ken Keller
Chairman of the Board, President and CEO, Daiichi Sankyo, Inc.

Anja König
Global Head, Novartis Venture Fund

Kasim Kutay
CEO, Novo Holdings

Nicole Mather
Life Sciences and Health Data & AI Lead, IBM Consulting

Clive Meanwell
Chairman, Managing Partner, Population Health Partners

Carina Namih
Partner, Plural

Kabir Nath
CEO, Compass Pathways

Marjan Noor
Partner and Life Sciences Sector Lead, A&O Shearman

Mishal Patel
Corporate Vice President, AI and Digital Research, Novo Nordisk

David Reddy
Director General, International Federation of Pharmaceutical Manufacturers and Associations

Nabiha Saklayen
CEO and Co-founder, Cellino

Kirsten Shastri
Head of Life Sciences, Tokio Marine Kiln

Monica Shaw
Senior Vice President, Head of European Markets, Bristol Myers Squibb

Michael Sherman
Venture Partner, RA Capital Management

Kris Sterkens
Company Group Chairman, EMEA, Johnson & Johnson Innovative Medicine

Helen Tayton-Martin
Chief Business and Strategy Officer, Adaptimmune

Padraic Ward
Head Pharma International, Roche

2024 Sponsors

LEAD SPONSORS:
• IFPMA
• Johnson&Johnson
• Novocure
• Roche

ASSOCIATE SPONSORS:
• A&O Shearman
• IBM